Search clinical trials for: ethinyl estradiol 35 mcg and drospirenone 3 mg

Total 463 results

Tyumen State Medical Academy

Unknown

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Hyperandrogenism | Polycystic Ovarian Syndrome | Menstrual Irregularities

Russian Federation
Estetra

Completed

"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

Contraception | Liver Metabolism | Hemostasis Parameter

Netherlands
Catholic University of the Sacred Heart

Completed

Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

Polycystic Ovary Syndrome | Estro-progestin Drugs

Italy
NewAmsterdam Pharma
Novum

Recruiting

Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

Healthy Volunteers

United States
Estetra

Completed

E4/DRSP Ovarian Function Inhibition Study

Prevention of Pregnancy

Netherlands
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Metabolic Syndrome in PCOS: Precursors and Interventions

Polycystic Ovary Syndrome | Metabolic Syndrome

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Healthy

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

Contraception
Janssen Research & Development, LLC

Terminated

A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females

Healthy

United States
Bio-innova Co., Ltd

Not yet recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Healthy Subjects
AGUNCO Obstetrics and Gynecology Centre

Completed

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Polycystic Ovary Syndrome | PCOS

Italy
Bio-innova Co., Ltd

Recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Healthy Subjects

Thailand
Regenex Pharmaceutical, China

Unknown

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

Oral Contraceptive

China
NewGiza University
Ain Shams University

Not yet recruiting

The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study

Observational Study
Bristol-Myers Squibb

Completed

A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Healthy Volunteers

Canada
Bayer

Completed

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

Contraceptives, Oral

Netherlands
Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
Massachusetts General Hospital
Bayer

Completed

The Oral Contraceptive Pill for Premenstrual Worsening of Depression

Depression | Premenstrual Syndrome

United States
Massachusetts General Hospital
Bayer

Completed

Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne

Acne Vulgaris

United States
Navy General Hospital, Beijing

Unknown

Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

Primary Ovarian Insufficiency | Menopause, Premature

China
Massachusetts General Hospital
Bayer

Terminated

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

Hidradenitis Suppurativa

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina

Terminated

Binge Eating & Birth Control

Binge-Eating Disorder | Bulimia Nervosa | Binge Eating | Eating Disorders

United States
Silva Arslanian
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

Polycystic Ovary Syndrome

United States
Chulalongkorn University

Not yet recruiting

"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

Ultrasound Finding: Ovulation Inhibition, Ovarian Activities | Cervical Mucus | Serum Hormonal Profile
Mahidol University

Unknown

Comparison of Body Weight Change During Contraception With Belara and Yasmin

Body Weight Changes

Thailand
National Institute of Mental Health (NIMH)

Terminated

Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

Depression | Premenstrual Dysphoric Disorder | Premenstrual Syndrome | PMS | PMDD

United States
Ain Shams Maternity Hospital

Unknown

Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri (LNG-IUDvsCOCs)

Adenomyosis

Egypt
Laboratorios Andromaco S.A.

Completed

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
Laboratorios Andromaco S.A.

Completed

Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

Bioequivalence

Chile
Guangdong Women and Children Hospital

Recruiting

Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

PCOS

China
Estetra

Completed

Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers

Contraception
University of Pennsylvania
Society of Family Planning

Terminated

Contraceptive Hormones and Women With Cystic Fibrosis

Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

Oral Contraceptive | Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

Bioequivalence

Chile
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

Bioequivalence

United States
Fudan University

Recruiting

Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety (PCOS)

Depression, Anxiety | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

China
Chulalongkorn University

Not yet recruiting

"Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

Ultrasound Finding: Ovulation Inhibition, Ovarian Activities | Cervical Mucus | Serum Hormonal Profile
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

Healthy

United States
Estetra
PRA Health Sciences

Completed

E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study

Contraception

Belgium
University of California, San Francisco

Completed

Continuous Versus Cyclical OCP Use in PCOS (CCOUP)

Polycystic Ovary Syndrome

United States
St. Joseph's Healthcare Hamilton
McMaster University; Hamilton Academic Health Sciences Organization

Recruiting

Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

Bipolar Disorder | Premenstrual Dysphoric Disorder

Canada
Catholic University of the Sacred Heart

Unknown

Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Italy
Bayer

Completed

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Hypertension | Postmenopause | Pre-Hypertension

United States
Bayer

Completed

Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Contraception | Neural Tube Defects | Oral Contraceptives (OC)

United States
Istanbul Training and Research Hospital

Withdrawn

Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality

Contraceptive Methods Comparison

Turkey
Boehringer Ingelheim

Terminated

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany
ViiV Healthcare
GlaxoSmithKline

Terminated

A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

HIV Infections | Infection, Human Immunodeficiency Virus

United States
Brigham and Women's Hospital
Bayer

Completed

Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

Cardiovascular Diseases

United States

3

Subscribe